The estimated Net Worth of Nicole Williams is at least 754 千$ dollars as of 20 November 2015. Nicole Williams owns over 973 units of Progenics Pharmaceuticals stock worth over 7,934$ and over the last 18 years Nicole sold PGNX stock worth over 745,788$.
Nicole has made over 13 trades of the Progenics Pharmaceuticals stock since 2013, according to the Form 4 filled with the SEC. Most recently Nicole exercised 973 units of PGNX stock worth 9,555$ on 20 November 2015.
The largest trade Nicole's ever made was selling 2,433 units of Progenics Pharmaceuticals stock on 25 August 2014 worth over 717,930$. On average, Nicole trades about 371 units every 22 days since 2007. As of 20 November 2015 Nicole still owns at least 1,935 units of Progenics Pharmaceuticals stock.
You can see the complete history of Nicole Williams stock trades at the bottom of the page.
Over the last 22 years, insiders at Progenics Pharmaceuticals have traded over 11,559,939$ worth of Progenics Pharmaceuticals stock and bought 2,672,016 units worth 11,900,148$ . The most active insiders traders include Healthcare Master Fund Ltd ...、Michael D Kishbauch、Bradley L Campbell. On average, Progenics Pharmaceuticals executives and independent directors trade stock every 16 days with the average trade being worth of 60,241$. The most recent stock trade was executed by Capital, L.P.Altiva Managem... on 9 September 2019, trading 72,023 units of PGNX stock currently worth 359,395$.
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.
Progenics Pharmaceuticals executives and other stock owners filed with the SEC include: